Han Kun represented SAIF in its investment in Beijing Huaxipharm Co., Ltd.'s equity financing
2013-03-01
SAIF completed its investment in Beijing Huaxipharm Co., Ltd.'s equity financing.
Han Kun represented SAIF in its investment in Beijing Huaxipharm Co., Ltd., a high-tech enterprise primarily engaged in research and development of new medicines.
Han Kun primarily assisted in the design of transaction structures and preparation of various transaction documents and participated in the negotiation process.
The leading lawyers involved in this deal are Charles Li, Loretta Li and Songsong Gao.